Preclinical Development of GR2002, a Novel Anti-TSLP Bispecific Antibody With Potent TSLP Inhibitory Effects.
Zhang, X., Luo, S., Hao, X., Liu, Y., Hu, J., Yang, J., Qin, H., Liu, Z.(2025) Allergy 80: 2077-2080
- PubMed: 40372096 
- DOI: https://doi.org/10.1111/all.16591
- Primary Citation of Related Structures:  
8ZEU - Beijing Wisdomab Biotechnology Co. Ltd, Beijing, China.
Organizational Affiliation: 



















